These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 15023405

  • 1. Animal models of tumor immunity, immunotherapy and cancer vaccines.
    Ostrand-Rosenberg S.
    Curr Opin Immunol; 2004 Apr; 16(2):143-50. PubMed ID: 15023405
    [Abstract] [Full Text] [Related]

  • 2. Immunoprevention of cancer: time to reconsider timing of vaccination against cancer.
    Spisek R.
    Expert Rev Anticancer Ther; 2006 Dec; 6(12):1689-91. PubMed ID: 17181481
    [No Abstract] [Full Text] [Related]

  • 3. Combinational adenovirus-mediated gene therapy and dendritic cell vaccine in combating well-established tumors.
    Xia D, Moyana T, Xiang J.
    Cell Res; 2006 Mar; 16(3):241-59. PubMed ID: 16541123
    [Abstract] [Full Text] [Related]

  • 4. A paradigm shift in therapeutic vaccination of cancer patients: the need to apply therapeutic vaccination strategies in the preventive setting.
    Gray A, Raff AB, Chiriva-Internati M, Chen SY, Kast WM.
    Immunol Rev; 2008 Apr; 222():316-27. PubMed ID: 18364011
    [Abstract] [Full Text] [Related]

  • 5. MMP11: a novel target antigen for cancer immunotherapy.
    Peruzzi D, Mori F, Conforti A, Lazzaro D, De Rinaldis E, Ciliberto G, La Monica N, Aurisicchio L.
    Clin Cancer Res; 2009 Jun 15; 15(12):4104-13. PubMed ID: 19509157
    [Abstract] [Full Text] [Related]

  • 6. Vaccination with an adenoviral vector encoding the tumor antigen directly linked to invariant chain induces potent CD4(+) T-cell-independent CD8(+) T-cell-mediated tumor control.
    Sorensen MR, Holst PJ, Pircher H, Christensen JP, Thomsen AR.
    Eur J Immunol; 2009 Oct 15; 39(10):2725-36. PubMed ID: 19637230
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Spatio-temporal control of oncogenesis].
    Giovannini M.
    Pathol Biol (Paris); 1998 Feb 15; 46(2):120-1. PubMed ID: 9769926
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Promises and limitations of murine models in the development of anticancer T-cell vaccines.
    Lévy F, Colombetti S.
    Int Rev Immunol; 2006 Feb 15; 25(5-6):269-95. PubMed ID: 17169777
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.